About 3,4-DMMC Powder

3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug that was first reported in 2010 as a designer drug analogue of mephedrone. It emerged in response to the banning of mephedrone, which had seen widespread abuse in various countries across Europe and beyond. 3,4-DMMC has been identified as a designer drug in Australia and is known for its psychoactive properties.

Chemical Nomenclature

• IUPAC Name: 3,4-Dimethylmethcathinone
• CAS Number: 1082110-00-6
• PubChem CID: 52988261
• ChemSpider: 25630192
• UNII: C4EW58DTW5

Chemical and Physical Data

• Formula: C12H17NO
• Molar Mass: 191.274 g·mol−1

Pharmacology

In vitro studies have shown that 3,4-DMMC acts as a monoamine transporter substrate, potently inhibiting norepinephrine and serotonin reuptake, while having a lesser effect on dopamine reuptake. This mechanism contributes to its stimulant effects.

Conclusion

3,4-Dimethylmethcathinone is a contemporary stimulant that has emerged in the designer drug market. Its structural similarities to mephedrone and its psychoactive properties make it a subject of interest for further research. However, due to the limited data on its effects and safety, users should approach this compound with caution and prioritize harm reduction practices.

3,4-DMMC Powder is for research use only and not intended for human consumption!

3,4-DMMC Powder stock last updated at: June 2025